Best NAD+ Supplements: NMN, NR, Niacin, and How to Choose

NAD+ (nicotinamide adenine dinucleotide) is one of the most critical molecules in your body. It fuels hundreds of enzymatic reactions, drives mitochondrial energy production, supports DNA repair, and regulates cellular aging. The problem: NAD+ levels decline steadily with age. By your 50s, you may have half the NAD+ you had at 20. By your 60s and beyond, the drop accelerates.
This decline isn’t just a laboratory curiosity. Lower NAD+ levels correlate with reduced energy, slower recovery, cognitive fog, metabolic dysfunction, and accelerated aging at the cellular level. Supplementing with NAD+ precursors has become one of the most popular strategies in longevity medicine, but the options can be confusing. NMN, NR, niacin, IV infusions: which one actually works, and which is right for you?
- At a Glance
- Why NAD+ Declines and Why It Matters
- The Three Main NAD+ Precursors
- NMN (Nicotinamide Mononucleotide)
- NR (Nicotinamide Riboside)
- Niacin (Vitamin B3 / Nicotinic Acid)
- Head-to-Head Comparison
- Brand Comparison: Who Makes What
- Why Third-Party Testing Matters
- Dosing Recommendations
- Oral Supplements vs. IV NAD+ Infusions
- When to Choose IV vs. Oral
- Combination Strategies
- Safety Considerations
- Safety Notes
- Bottom Line: How to Choose
- References
- Related Reading
At a Glance
- NAD+ levels drop significantly with age, contributing to fatigue, cognitive decline, and slower cellular repair.
- Three main oral precursors can boost NAD+: NMN (nicotinamide mononucleotide), NR (nicotinamide riboside), and niacin (vitamin B3).
- NR has the most published human clinical trial data. NMN is catching up quickly with several completed trials.
- Niacin is the cheapest option and raises NAD+ effectively, but causes flushing in most people.
- IV NAD+ infusions bypass digestion entirely and produce the fastest, most dramatic results, but cost significantly more.
- Third-party testing (NSF, ConsumerLab, Informed Sport) is critical because the supplement market is poorly regulated.
- The best choice depends on your budget, goals, evidence comfort level, and whether you want daily maintenance or intensive restoration.
Why NAD+ Declines and Why It Matters
NAD+ sits at the center of cellular metabolism. It shuttles electrons in the mitochondria to generate ATP (your cell’s energy currency), activates sirtuins (a family of proteins that regulate inflammation, DNA repair, and aging), and serves as a substrate for PARPs (enzymes that repair DNA damage).
The decline happens for several reasons. Chronic inflammation increases the activity of CD38, an enzyme that consumes NAD+. DNA damage accumulates with age, demanding more PARP activity, which also uses NAD+. Meanwhile, the body’s ability to synthesize NAD+ from dietary precursors becomes less efficient over time.
The result is an energy deficit at the cellular level. Your mitochondria produce less ATP. Your DNA repair slows. Sirtuin activity drops. This cascade contributes to many of the symptoms people associate with “normal aging,” including fatigue, brain fog, slower recovery from exercise or illness, and metabolic changes like insulin resistance.
The Three Main NAD+ Precursors
Your body can make NAD+ from several precursor molecules. The three that matter most for supplementation are NMN, NR, and niacin. Each enters the NAD+ biosynthesis pathway at a different point, and each has distinct advantages and drawbacks.
NMN (Nicotinamide Mononucleotide)
NMN is one enzymatic step away from NAD+ itself. In the biosynthesis pathway, NMN is converted directly to NAD+ by the enzyme NMNAT. This proximity to the end product is one of the reasons NMN has attracted so much attention, particularly from Dr. David Sinclair’s lab at Harvard, which has published extensively on NMN’s effects in animal models.
There was a longstanding debate about whether NMN could enter cells directly or needed to be converted to NR first. In 2019, researchers identified a transporter called Slc12a8 in the gut that appears to allow direct NMN uptake, at least in mice. The relevance of this transporter in humans is still being studied, but several human trials have now confirmed that oral NMN supplementation does raise blood NAD+ levels.
Published human trials show NMN at doses of 250 to 1,250 mg per day increases NAD+ metabolites in blood, improves muscle insulin sensitivity in older adults, and may improve aerobic capacity. A 2022 study in Science showed NMN improved muscle insulin sensitivity and remodeling in postmenopausal women with prediabetes.
Typical dose: 250 to 1,000 mg daily.
Cost: $40 to $80 per month for quality brands.
Form: Capsules, sublingual powder, or enteric-coated tablets.
NR (Nicotinamide Riboside)
NR enters the NAD+ pathway through the NRK1 enzyme, which converts it to NMN, which is then converted to NAD+. So NR is two steps away from NAD+, compared to NMN’s one step. This doesn’t necessarily make it less effective. The NRK1 pathway is well-established and highly efficient in human cells.
NR’s biggest advantage is its clinical evidence base. Niagen, the patented form of NR made by ChromaDex, has been used in more published human clinical trials than any other NAD+ precursor. These studies have consistently shown that NR at 300 to 1,000 mg daily raises whole blood NAD+ levels by 40 to 90%, with good safety profiles across study durations of up to 12 weeks.
NR has also shown benefits in specific clinical populations. Studies have demonstrated improvements in blood pressure, arterial stiffness, and exercise performance in older adults. A trial in heart failure patients showed favorable changes in mitochondrial respiration. Research in Parkinson’s disease patients showed increased brain NAD+ levels on MRI spectroscopy.
Typical dose: 300 to 1,000 mg daily.
Cost: $30 to $60 per month (Tru Niagen is the most widely available brand).
Form: Capsules.
Niacin (Vitamin B3 / Nicotinic Acid)
Niacin is the original NAD+ precursor, and it’s dirt cheap. Your body converts niacin to NAD+ through the Preiss-Handler pathway, a well-characterized biochemical route that has been understood for decades. At doses of 500 to 1,000 mg, niacin reliably increases NAD+ levels.
The catch is flushing. Niacin activates a receptor called GPR109A on skin cells, triggering the release of prostaglandins that cause intense redness, warmth, and tingling, usually in the face and upper body. This effect is harmless but uncomfortable, and it causes many people to stop taking niacin. Extended-release formulations reduce flushing but carry a small risk of liver toxicity at high doses.
Nicotinamide (also called niacinamide) is a related form that doesn’t cause flushing, but at high doses it can inhibit sirtuin activity, which partially defeats the purpose of raising NAD+ in the first place.
Typical dose: 500 to 1,000 mg daily (start low, build up to manage flushing).
Cost: $5 to $15 per month.
Form: Tablets, extended-release tablets.
Head-to-Head Comparison
| Factor | NMN | NR (Niagen) | Niacin |
|---|---|---|---|
| Steps to NAD+ | 1 (NMN to NAD+) | 2 (NR to NMN to NAD+) | 3 (via Preiss-Handler pathway) |
| Human RCTs | Several completed (growing) | Most published data | Extensive (decades of data) |
| NAD+ increase | 40 to 80% (varies by study) | 40 to 90% (well-documented) | Significant (dose-dependent) |
| Cost per month | $40 to $80 | $30 to $60 | $5 to $15 |
| Side effects | Generally mild (GI occasionally) | Generally mild | Flushing (common, intense) |
| Sirtuin inhibition risk | No | No | No (but nicotinamide form does) |
| Absorption | Good (sublingual may be superior) | Good (oral capsule) | Excellent (oral) |
| FDA status | Supplement (after reversal of 2022 NDI issue) | Supplement (FDA GRAS, self-affirmed) | Supplement / OTC drug |
Brand Comparison: Who Makes What
The NAD+ precursor market is crowded, and product quality varies enormously. Here are some of the more established brands with third-party testing.
| Brand | Product | Precursor | Dose/Serving | Third-Party Tested | Approx. Monthly Cost |
|---|---|---|---|---|---|
| Tru Niagen | Niagen NR | NR | 300 mg | NSF Contents Certified | $40 to $50 |
| ProHealth Longevity | NMN Pro | NMN | 500 mg | Third-party COA available | $45 to $60 |
| DoNotAge | Pure NMN | NMN | 500 mg to 1 g | Third-party COA available | $35 to $55 |
| Alive By Nature | Sublingual NMN | NMN | 250 mg (sublingual) | Third-party COA available | $40 to $50 |
| Elysium Health | Basis | NR + pterostilbene | 250 mg NR | Published clinical trial on product | $50 to $60 |
Why Third-Party Testing Matters
The supplement industry in the United States is largely self-regulated. Companies can sell products without proving purity, potency, or safety to the FDA before they hit shelves. Independent testing by organizations like NSF International, ConsumerLab, and USP provides an extra layer of verification. These certifiers test for accurate labeling, contaminant screening (heavy metals, microbial contamination), and in some cases, banned substance screening for athletes.
When choosing a NAD+ precursor supplement, look for a current certificate of analysis (COA) from a third-party lab. Reputable brands make these available on their websites or upon request. If a company won’t share testing data, that’s a red flag.
Dosing Recommendations
There is no FDA-established dose for NMN or NR as NAD+ boosters. Recommendations are based on published clinical trials, pharmacokinetic data, and clinical experience from practitioners working in longevity medicine.
NMN: Most human trials have used 250 to 1,250 mg daily. A reasonable starting dose is 250 to 500 mg in the morning (NAD+ is involved in circadian rhythm regulation, so morning dosing aligns with your body’s natural cycle). Some people titrate up to 1,000 mg based on response.
NR: Clinical trials typically use 300 to 1,000 mg daily. Tru Niagen’s standard dose is 300 mg, but many longevity practitioners recommend 600 to 1,000 mg for therapeutic purposes. Like NMN, morning dosing is generally preferred.
Niacin: Start at 100 to 250 mg with food and increase gradually over weeks. The flushing response diminishes with consistent daily use. Taking an aspirin 30 minutes before your dose can reduce flushing. Extended-release niacin should be capped at 1,500 mg daily due to liver concerns, and liver function should be monitored periodically.
Oral Supplements vs. IV NAD+ Infusions
Oral precursors are convenient and relatively affordable for daily use. But they have inherent limitations. First-pass metabolism in the liver means a significant portion of the ingested precursor is processed before reaching systemic circulation. The conversion efficiency from precursor to NAD+ varies between individuals based on enzyme activity, gut health, and other factors.
IV NAD+ infusions deliver the molecule directly into the bloodstream, completely bypassing digestion and first-pass metabolism. The result is a rapid, substantial spike in circulating NAD+ that oral supplements simply cannot match. Many patients report noticeable improvements in energy, mental clarity, and overall well-being during or shortly after an infusion series.
The tradeoff is cost ($250 to $1,000 per infusion), time (infusions typically take 2 to 4 hours), and access (you need a clinic that offers them). IV NAD+ can also cause nausea, chest tightness, and cramping during the infusion, especially at higher doses or faster drip rates. These effects are temporary and manageable by adjusting the infusion speed.
When to Choose IV vs. Oral
Choose oral precursors if: You want daily NAD+ maintenance at a reasonable cost, you’re generally healthy and looking for longevity support, or you prefer convenience over intensity.
Choose IV NAD+ if: You’re dealing with significant fatigue, cognitive decline, addiction recovery, or neurodegenerative concerns. If you want rapid restoration of depleted NAD+ stores, or if oral supplementation hasn’t produced noticeable results after 2 to 3 months of consistent use.
Many people use both: IV infusions for periodic intensive restoration (a series of 3 to 6 infusions once or twice per year) and daily oral precursors for maintenance between infusion cycles.
Combination Strategies
Some practitioners and longevity researchers recommend pairing NAD+ precursors with complementary compounds for synergistic effects.
NMN + TMG (trimethylglycine): NMN and NR metabolism produces nicotinamide as a byproduct. Clearing nicotinamide requires methylation, which consumes methyl groups. TMG donates methyl groups, supporting this clearance pathway and preventing potential methyl donor depletion. Many NMN users take 500 to 1,000 mg of TMG alongside their NMN dose.
NMN or NR + Resveratrol: David Sinclair’s research suggests that resveratrol activates sirtuins, while NAD+ serves as the fuel sirtuins need to function. The analogy is that resveratrol is the gas pedal and NAD+ is the fuel. Whether this combination produces meaningful clinical benefits in humans beyond what either compound does alone is still an open question, but the mechanistic rationale is sound.
NAD+ precursor + Apigenin or Quercetin: These flavonoids inhibit CD38, the enzyme that breaks down NAD+. By slowing NAD+ degradation while simultaneously boosting production with a precursor, you may get more out of each dose. Apigenin (found in chamomile) and quercetin (found in onions and apples) are available as supplements, typically dosed at 50 to 500 mg daily.
Safety Considerations
Safety Notes
- NMN and NR have shown good safety profiles in published human trials at standard doses, but long-term data (beyond 12 to 16 weeks) is still limited.
- There is a theoretical concern that boosting NAD+ could fuel the growth of existing cancers, since cancer cells also use NAD+ for energy and survival. No human data supports this as a practical risk at supplemental doses, but if you have an active malignancy, discuss NAD+ supplementation with your oncologist.
- Niacin at high doses requires liver function monitoring. The extended-release form carries more liver risk than immediate-release.
- IV NAD+ infusions can cause nausea, chest pressure, and abdominal cramping during administration. These resolve quickly when the infusion rate is slowed.
- If you take medications that affect NAD+ metabolism (certain chemotherapy drugs, for example), consult your physician before starting any NAD+ precursor.
Bottom Line: How to Choose
If evidence base is your top priority, start with NR (Tru Niagen). It has the most robust human clinical trial data, NSF certification, and a straightforward dosing protocol.
If you want to be closer to the cutting edge and you’re comfortable with a slightly smaller (but growing) evidence base, NMN is a strong choice. Sublingual forms may offer better absorption. Pair with TMG for methylation support.
If cost is the primary concern and you can tolerate flushing, niacin raises NAD+ effectively for pennies a day. It’s not glamorous, but it works.
If you’re dealing with significant health challenges or want rapid results, consider IV NAD+ infusions for initial restoration, then transition to daily oral precursors for maintenance.
Whatever you choose, buy from brands that provide third-party testing data, start at the lower end of the dosing range, and give any supplement at least 4 to 8 weeks before evaluating results. NAD+ restoration is a gradual process, not an overnight fix.
References
- Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513-528. doi:10.1016/j.cmet.2017.11.002
- Grozio A, Mills KF, Yoshino J, et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab. 2019;1(1):47-57. doi:10.1038/s42255-018-0009-4
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. doi:10.1126/science.abe9985
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7
- Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28(7):1717-1728. doi:10.1016/j.celrep.2019.07.043
- Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. doi:10.1038/ncomms12948
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772. doi:10.1038/s41598-019-46120-z
- Brakedal B, Dolle C, Riber F, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metab. 2022;34(3):396-407. doi:10.1016/j.cmet.2022.02.001




